The application of behavioral economic demand theory in addiction science has proved useful for evaluating individual characteristics underlying abuse liability. Two factors that have received comparably little attention within this literature are sex and gonadal hormones. We determined cocaine and remifentanil demand in male and female rats using a within-session procedure. Cocaine and remifentanil demand were evaluated for 15 consecutive days using a balanced, crossover design that randomized drug order. This design allowed for the evaluation of temporal and exposure effects on two independent dimensions of demand, unconstrained demand (Q 0 ) and demand elasticity (α). Estrous cyclicity was tracked to determine the contribution of phase to demand. No overall sex differences were observed. Increased unconstrained demand for cocaine and remifentanil was observed in females during periods in which estrogen was high (eg, estrus phase). Unconstrained remifentanil demand escalated over the 15-day testing period, but escalation was not observed for cocaine or for demand elasticity. A significant exposure effect was also observed in which greater prior remifentanil intake increased unconstrained cocaine demand and reduced cocaine demand elasticity. These effects were directionally specific as no significant effects of prior cocaine exposure were observed on remifentanil demand measures.
mechanisms underlying drug reinforcement. Specifically, theoretical and empirical data support the notion that demand can be separated into two independent behavioral mechanisms: (1) consumption of demand at unconstrained price (ie, a hedonic set point, also referred to as demand intensity) and (2) elasticity of demand (ie, sensitivity of consumption to changes in price 4, 5 ). This literature has also supported the translational and clinical utility of these measures as reflecting distinct features of reinforcement that relate to risk factors underlying substance use disorder (see reviews in Kaplan et al 6 ; MacKillop 3 ). It is in this separation of behavioral mechanisms that behavioral economic demand has the potential to advance previous research on the relative reinforcing effects of drugs by accounting for the multidimensional nature of reinforcement rather than viewing reinforcement as a homogenous construct. 5, 7 Demand curves are typically generated in preclinical research by allowing subjects to self-administer a drug over multiple days on varying fixed-ratio (FR) schedules and/or across different drug doses. 5, 8, 9 One limitation of this methodology is that it can be time intensive, requiring subjects to be tested over numerous days with only one unit price determined in each session. An alternative to these betweensession approaches is the threshold procedure (see review by Bentzley et al 10 ) . The threshold procedure generates demand functions by systematically reducing the dose delivered within discrete components of a single test session. Such methods have proved valuable for a wide array of applications including examining putative pharmacotherapies (eg, Bentzley et al 11 ) , determining the effects of stress on drug selfadministration, 12, 13 and evaluating the neurobiological mechanisms related to drug reinforcement. 14 One important individual characteristic related to substance use and substance use disorder is sex. Clinical and preclinical research examining sex differences in drug addiction point to a consistently cited conclusion: Females are more vulnerable to the reinforcing effects of drugs than males. 15, 16 These differences are typically attributed to gonadal hormones, particularly estrogen, that are thought to augment drug use behaviors. 17, 18 For example, women report increased subjective drug effects during the follicular phase of the menstrual cycle during which estrogen levels are high. 19, 20 Similarly, female rats reach higher cocaine breakpoints on a progressive-ratio schedule of reinforcement during the estrus phase of the estrous cycle, when estrogen is high. [21] [22] [23] Surprisingly, little is known about the extent to which sex differences and hormonal fluctuations may impact drug demand characteristics within a behavioral economic framework. One preclinical study using the between-session demand procedure did not detect differences in unconstrained nicotine demand or demand elasticity between male and female rats, 24 which is consistent with research conducted in the human laboratory and clinic. [25] [26] [27] Few studies have systematically evaluated sex as it relates to drug demand in humans.
Notably, however, a recent experiment found that women in the follicular, compared with luteal, phase showed elevated demand for cigarettes consistent with the research reviewed above. 28 At the time of this study, no preclinical studies had systematically evaluated sex and hormonal differences in cocaine and opioid demand or evaluated the effects of estrous phase on drug demand. This represents a significant limitation given that preclinical research allows for the specific evaluation of the effects of gonadal hormones on drug abuse liability. The threshold procedure is well positioned to address these gaps given the ability to generate demand curves within a single day or session thereby allowing for high-throughput and highresolution evaluation of changes in demand as a function of individual subject characteristics (eg, hormonal fluctuations).
The primary goal of the present study was to evaluate sex and estrous cycle differences in cocaine and remifentanil demand. To this end, male and female rodents were tested using a threshold procedure for 15 consecutive days for cocaine or remifentanil administration. Subjects then completed an additional 15 days of testing for the other compound. This crossover design allowed us to accomplish two secondary goals. First, we evaluated whether demand was stable over the 15-day period. Second, we evaluated whether prior drug exposure (eg, cocaine) altered demand for other compounds from a different pharmacological class (eg, remifentanil). We predicted that female subjects would exhibit behavior consistent with greater abuse liability (ie, increased unconstrained demand and decreased demand elasticity) consistent with previous research on cocaine and opioids using alternative models. 18, 29, 30 We also predicted that estrous cycle would differentially impact cocaine and remifentanil demand consistent with previous research. 21, 31, 32 2 | MATERIALS AND METHODS
| Animals
Thirty-two Long-Evans rats (16 male, 16 female) were obtained at weaning and raised until early adulthood (postnatal day 75). Rats were singly housed in standard polycarbonate cages (interior dimensions: 50 × 28 × 30 cm) within a temperature-and humidity-controlled colony room maintained on a 12-hour light/dark cycle (lights on: 07:00 AM). Food and water were freely available except during the brief period of lever-press training (see Section 2.2). All animals were maintained in accordance with the Guide for the Care and Use of Laboratory Animals. 33 All procedures were approved by the Animal Care and Use Committee at Franklin & Marshall College.
| Lever-press training
At approximately 75 days old, rats were placed on light food restriction and maintained at 90% of free-feeding weight. Animals were then trained to press a response lever to obtain food reinforcement (Bio-Serv, Dustless Precision Pellets, 45 mg) in operant conditioning chambers from Med Associates Inc (Georgia, Vermont) on a fixed-ratio 1 (FR1) schedule.
All sessions terminated automatically once 50 reinforcers had been delivered or 2 hours elapsed, whichever occurred first. Once a rat earned 50 reinforcers on three consecutive training sessions, they were placed back on unrestricted feed and training was discontinued.
| Surgery
Approximately 1 week following food training, rats were anesthetized using a combination of ketamine HCl (100 mg/kg, ip) and xylazine HCl (8.0 mg/kg, ip). An intravenous catheter was surgically implanted into the right jugular vein and exited the body on the dorsal surface of the scapulae. Carprofen (5.0 mg/kg, sc) was given immediately after surgery and on the following day as a postoperative analgesic, and a solution of heparinized saline and ticarcillin (20 mg/kg, iv) was infused through the catheter daily as a prophylactic antibiotic and to maintain catheter patency. Ticarcillin was given for 7 days following surgery, including the first 3 days of behavioral testing (ie, during selfadministration training). After ticarcillin administration was discontinued, a solution of heparinized saline and gentamicin (0.05 mg/kg) was used to maintain patency. All animals were allowed 4 days to recover before self-administration training and testing. 
| Self-administration training

| Threshold testing
Threshold testing began 5 days after self-administration training.
Details on the threshold procedure are described elsewhere. 14 The first 10-m (initiation) phase was designed to account for and avoid inflated estimations due to an initial "load up" phase of selfadministration and was not included in data analysis. 10 
| Vaginal lavage and monitoring of the estrous cycle
The estrous cycle of all female subjects was monitored daily, beginning 7 days prior to catheter implantation in order to establish a pattern of estrous cyclicity for each animal. Sampling was suspended during the surgery/recovery period and resumed on the first day of selfadministration. Vaginal samples were obtained using a standard lavage technique in which approximately 0.5 mL of physiological saline (0.9%) was used to flush the vaginal canal and allow surface cells to be collected for analysis. Samples were analyzed under 100× light microscopy for determination of estrous cycle. All lavage samples were collected less than 30 m before each self-administration test session began. There are four phases in the rat estrous cycle: diestrus, proestrus, estrus, and metaestrus. These phases can be identified based on the proportion of three types of vaginal cells present in a given sample. 34, 35 These cells are leukocytes (L), nucleated (N), and cornified (C) epithelial cells. The cycle of estrous was determined using the following guidelines:
For the purposes of this experiment, metaestrus and diestrus (denoted as M/D herein) were combined for data analysis purposes due to the low levels of estrogen that characterize these phases. [21] [22] [23] 
| Data analysis
Individual subject estimates of unconstrained demand (Q 0 ) and demand elasticity (α) were determined using the exponentiated demand equation 36 :
where Q is the consumption; Q 0 is the derived unconstrained demand;
k is a constant related to consumption range (a priori set to 2); C is the unit price (ie, responses required at each component dose to reach the However, the use of linear mixed-effect models and maximum likelihood estimation described below allowed for the inclusion of subjects with any missing data in full model estimation. Unconstrained demand and elasticity were skewed and log-transformed prior to inferential analysis to satisfy normality assumptions. Additional models were used to evaluate the effects of prior drug exposure on unconstrained demand and elasticity. These models tested the relationship between average unconstrained demand throughout testing of the first drug exposure and the unconstrained demand and elasticity for the second drug tested in threshold. For example, models with subjects tested for remifentanil demand first evaluated the relationship between average unconstrained demand for remifentanil (predictor) and cocaine unconstrained demand and elasticity (outcomes). Significant effects were followed by simple slopes estimation for interpretation purposes.
All analyses were conducted in R using two-tailed tests and a type I error rate of 0.05. 
| RESULTS
| Estimates over the study period
| Estrous phase effects
| Contribution of drug history to demand intensity and elasticity
A significant effect of remifentanil exposure on unconstrained cocaine demand was observed. Specifically, subjects exposed to Although a large number preclinical studies have identified an increased vulnerability to the reinforcing effects of drugs in females, some studies report no sex differences when assessing the reinforcing effects of drugs (see Becker et al 16 ). Of particular note, the only other preclinical study at the time of this study to systematically evaluate sex differences in drug demand found no differences between male and female rats in nicotine demand. 24 A contemporaneously conducted study also found no differences in cocaine demand between male and female rats during baseline testing consistent with the results reported here. 38 In the human laboratory, sex differences in cocaine demand were not found in one study, 39 but others have reported more inelastic cocaine demand 37 and higher unconstrained opioid demand 40 in men. These findings combined with the current results highlight the complex interaction that sex differences may have Despite the lack of robust sex differences, clear effects of estrous cyclicity were observed for unconstrained cocaine and remifentanil demand. These findings are consistent with prior preclinical work that has identified augmented drug effects during periods of the estrous phase in which estrogen circulation is high (see Anker and Carroll 15 for review). These findings are also consistent with human laboratory work that shows greater unconstrained demand for cigarettes during the follicular compared with luteal phase. 28 While the present study does support previous findings indicating that drug self-administration behavior is elevated during the estrus phase of freely cycling females, we did not find a reduction in unconstrained cocaine demand during proestrus. Overall, progesterone levels (and its metabolites) peak in proestrus, immediately prior to estrus, and have been shown to attenuate cocaine self-administration when progestins were administered exogenously. 41, 42 One potential explanation for the difference reported here is the use of a previously untested procedure to evaluate the effects of estrous cycle (ie, the within-session threshold procedure). As noted above, this procedure allowed us to partition drugtaking behavior into two unique behavioral mechanisms (ie, unconstrained demand and elasticity), and it is possible that estrous phase impacts these specific mechanisms in a different way than it impacts more traditional and global metrics of drug reinforcement. Future studies may also increase the precision of detecting circulating gonadal hormone levels by collecting blood samples during threshold testing. 22 In this regard, we also did not observe an effect on demand Estimates were generated for a subject at the average unconstrained remifentanil demand value, one standard deviation below this average (low unconstrained demand) and one standard deviation above this average (high unconstrained demand). Plots depict the modeled relationship between varying levels of unconstrained remifentanil demand and recorded cocaine values. Subjects with a prior history of remifentanil exposure first completed threshold testing for remifentanil then cocaine (a significant relationship was observed for both outcomes). Subjects with no prior history first completed threshold testing for cocaine then remifentanil (no significant relationship was observed for both outcomes). Error bars represent standard error utility of measuring the distinct behavioral mechanisms underlying drug reinforcement that are offered by demand procedures.
The secondary goals of this study included evaluating temporal and exposure effects on drug demand. These aims were accomplished through the use of a longitudinal crossover design in which subjects were randomized to testing order. We detected an increase in unconstrained remifentanil demand across the 15-day testing period representing an escalation of drug taking in the 2-hour testing session.
Escalation is typically identified using animal models in which subjects are given longer access to drug (eg, 6 h). However, escalation has also been observed using 1-hour test sessions and in this way has been suggested to relate to context-dependent discrimination learning. 47 It is possible that such discrimination learning could explain the escalation observed here in that subjects learned to discriminate between the individual components of a session using the dose available and subsequently increased intake during the early session components to maximize responding at low unit price. However, this explanation would not fully account for the observation that escalation was observed with remifentanil and not cocaine. Increases in model fit were also observed over the 15-day period, which could indicate that behavior was increasingly systematic and controlled by the parameters of the testing procedure. Important to note, however, is that the inclusion of model fit did not change the reported results demonstrating that these findings were not a product of increases in systematic responding or practice and training effects.
A robust and pronounced exposure effect was observed in which subjects first exposed to remifentanil showed higher levels of unconstrained demand and more inelastic demand for cocaine that was significantly associated with the extent of unconstrained remifentanil demand. A similar relationship was not found for subjects first exposed to cocaine indicating that this relationship was likely due to pharmacological exposure and directionally specific. These associations also did not differ by sex or estrous cycle suggesting a generalizability across these individual difference factors. Exposure-dependent increases in cocaine demand following opioid use are consistent with both prior preclinical and clinical work. For example, nonhuman primates show more inelastic and higher unconstrained demand for cocaine during morphine withdrawal as well as 4 to 5 weeks after chronic exposure. 9 Clinically, cocaine administration reduces the overall severity of naloxone-precipitated withdrawal in humans. 48 This reduction in opioid withdrawal symptomology may partially explain the observed results in the present study. Specifically, it has been shown that noradrenergic activity becomes hyperactive in opioid withdrawal and this hyperactivity may be attenuated through cocaine-induced reductions in norepinephrine release via alpha-2 autoreceptor activation. 49 Our findings combined with prior literature suggest the need to further examine the mechanisms by which opioid use promotes the observed increases in psychomotor stimulant use.
The results of this study should be considered within the context of its limitations. Model fits for the exponentiated demand equation were generally higher for remifentanil than cocaine, which could indicate a greater validity for the remifentanil findings. However, as noted above, controlling for model fit in the tested models did not alter the pattern or significance of results. Strain-dependent effects were not evaluated, and only Long-Evans rats were used. This may be particularly relevant for the sex or estrous differences given prior research demonstrating sex by strain interactions in substance-related behaviors (eg, Jones et al 50 ). We also did not manipulate gonadal hormone levels and instead relied upon variations across freely cycling estrous phases. This approach provides some benefits given the noninvasive nature of the method and similarities to natural fluctuations observed in the human condition. Nevertheless, future studies should evaluate the effects of experimentally manipulated gonadal hormones on measures of drug demand.
This study represents one of the first systematic preclinical evaluations of the effects of sex and estrous cycle on cocaine and opioid demand. These data suggested minimal overt differences in demand outcomes between male and female subjects; however, these indicated that unconstrained demand, but not elasticity, was associated with estrous cyclicity. We also found evidence for the escalation of unconstrained opioid demand over a 15-day period and that opioid exposure enhances subsequent unconstrained demand and reduces elasticity for psychomotor stimulants. Collectively, these findings contribute to the ongoing literature utilizing behavioral economic demand to understand behavioral mechanisms underlying individual differences in substance use.
